Watermark
  Back to Search Results

BGB-3111-205

Completed

Efficacy and Safety of Zanubrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-3111-205

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT03206918

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20160890

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

Study Documents

Study Protocol Statistical Analysis Plan